397 related articles for article (PubMed ID: 32066445)
1. Vascular miR-181b controls tissue factor-dependent thrombogenicity and inflammation in type 2 diabetes.
Witkowski M; Witkowski M; Saffarzadeh M; Friebel J; Tabaraie T; Ta Bao L; Chakraborty A; Dörner A; Stratmann B; Tschoepe D; Winter SJ; Krueger A; Ruf W; Landmesser U; Rauch U
Cardiovasc Diabetol; 2020 Feb; 19(1):20. PubMed ID: 32066445
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-19a contributes to the epigenetic regulation of tissue factor in diabetes.
Witkowski M; Tabaraie T; Steffens D; Friebel J; Dörner A; Skurk C; Witkowski M; Stratmann B; Tschoepe D; Landmesser U; Rauch U
Cardiovasc Diabetol; 2018 Feb; 17(1):34. PubMed ID: 29477147
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-181b inhibits thrombin-mediated endothelial activation and arterial thrombosis by targeting caspase recruitment domain family member 10.
Lin J; He S; Sun X; Franck G; Deng Y; Yang D; Haemmig S; Wara AK; Icli B; Li D; Feinberg MW
FASEB J; 2016 Sep; 30(9):3216-26. PubMed ID: 27297585
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-181b regulates NF-κB-mediated vascular inflammation.
Sun X; Icli B; Wara AK; Belkin N; He S; Kobzik L; Hunninghake GM; Vera MP; ; Blackwell TS; Baron RM; Feinberg MW
J Clin Invest; 2012 Jun; 122(6):1973-90. PubMed ID: 22622040
[TBL] [Abstract][Full Text] [Related]
5. Micro-RNA-126 Reduces the Blood Thrombogenicity in Diabetes Mellitus via Targeting of Tissue Factor.
Witkowski M; Weithauser A; Tabaraie T; Steffens D; Kränkel N; Witkowski M; Stratmann B; Tschoepe D; Landmesser U; Rauch-Kroehnert U
Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1263-71. PubMed ID: 27127202
[TBL] [Abstract][Full Text] [Related]
6. Metformin Is Associated with Reduced Tissue Factor Procoagulant Activity in Patients with Poorly Controlled Diabetes.
Witkowski M; Friebel J; Tabaraie T; Grabitz S; Dörner A; Taghipour L; Jakobs K; Stratmann B; Tschoepe D; Landmesser U; Rauch U
Cardiovasc Drugs Ther; 2021 Aug; 35(4):809-813. PubMed ID: 32940892
[TBL] [Abstract][Full Text] [Related]
7. Systemic delivery of microRNA-181b inhibits nuclear factor-κB activation, vascular inflammation, and atherosclerosis in apolipoprotein E-deficient mice.
Sun X; He S; Wara AKM; Icli B; Shvartz E; Tesmenitsky Y; Belkin N; Li D; Blackwell TS; Sukhova GK; Croce K; Feinberg MW
Circ Res; 2014 Jan; 114(1):32-40. PubMed ID: 24084690
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1β/nuclear factor-κB signaling promotes osteosarcoma cell growth through the microRNA-181b/phosphatase and tensin homolog axis.
Wang W; Wang Z; Chen S; Zang X; Miao J
J Cell Biochem; 2019 Feb; 120(2):1763-1772. PubMed ID: 30977354
[TBL] [Abstract][Full Text] [Related]
9. MiR-520b inhibits endothelial activation by targeting NF-κB p65-VCAM1 axis.
Yang B; Yang H; Lu X; Wang L; Li H; Chen S; Wang X; Shen C; Huang J; Lu X; Gu D
Biochem Pharmacol; 2021 Jun; 188():114540. PubMed ID: 33819467
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-223 inhibits tissue factor expression in vascular endothelial cells.
Li S; Chen H; Ren J; Geng Q; Song J; Lee C; Cao C; Zhang J; Xu N
Atherosclerosis; 2014 Dec; 237(2):514-20. PubMed ID: 25463083
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D modulates tissue factor and protease-activated receptor 2 expression in vascular smooth muscle cells.
Martinez-Moreno JM; Herencia C; Montes de Oca A; Muñoz-Castañeda JR; Rodríguez-Ortiz ME; Díaz-Tocados JM; Peralbo-Santaella E; Camargo A; Canalejo A; Rodriguez M; Velasco-Gimena F; Almaden Y
FASEB J; 2016 Mar; 30(3):1367-76. PubMed ID: 26700731
[TBL] [Abstract][Full Text] [Related]
12. Endothelial cell activation is attenuated by everolimus via transcriptional and post-transcriptional regulatory mechanisms after drug-eluting coronary stenting.
Fejes Z; Czimmerer Z; Szük T; Póliska S; Horváth A; Balogh E; Jeney V; Váradi J; Fenyvesi F; Balla G; Édes I; Balla J; Kappelmayer J; Nagy B
PLoS One; 2018; 13(6):e0197890. PubMed ID: 29889836
[TBL] [Abstract][Full Text] [Related]
13. Factor Xa induces tissue factor expression in endothelial cells by P44/42 MAPK and NF-κB-dependent pathways.
Jiang R; Wang NP; Tanaka KA; Levy JH; Guyton RA; Zhao ZQ; Vinten-Johansen J
J Surg Res; 2011 Aug; 169(2):319-27. PubMed ID: 20451919
[TBL] [Abstract][Full Text] [Related]
14. Decrease of intracellular chloride concentration promotes endothelial cell inflammation by activating nuclear factor-κB pathway.
Yang H; Huang LY; Zeng DY; Huang EW; Liang SJ; Tang YB; Su YX; Tao J; Shang F; Wu QQ; Xiong LX; Lv XF; Liu J; Guan YY; Zhou JG
Hypertension; 2012 Nov; 60(5):1287-93. PubMed ID: 23006728
[TBL] [Abstract][Full Text] [Related]
15. Hepatic miR-181b-5p Contributes to Glycogen Synthesis Through Targeting EGR1.
Wang S; Liang C; Ai H; Yang M; Yi J; Liu L; Song Z; Bao Y; Li Y; Sun L; Zhao H
Dig Dis Sci; 2019 Jun; 64(6):1548-1559. PubMed ID: 30627917
[TBL] [Abstract][Full Text] [Related]
16. Does hsa-miR-223-3p from platelet-derived extracellular vesicles regulate tissue factor expression in monocytic cells?
Collier MEW; Ambrose AR; Goodall AH
Platelets; 2022 Oct; 33(7):1031-1042. PubMed ID: 35132909
[TBL] [Abstract][Full Text] [Related]
17. Role of the phosphatidylinositol 3-kinase/protein kinase B pathway in regulating alternative splicing of tissue factor mRNA in human endothelial cells.
Eisenreich A; Malz R; Pepke W; Ayral Y; Poller W; Schultheiss HP; Rauch U
Circ J; 2009 Sep; 73(9):1746-52. PubMed ID: 19597299
[TBL] [Abstract][Full Text] [Related]
18. Alternatively spliced tissue factor and full-length tissue factor protect cardiomyocytes against TNF-α-induced apoptosis.
Boltzen U; Eisenreich A; Antoniak S; Weithaeuser A; Fechner H; Poller W; Schultheiss HP; Mackman N; Rauch U
J Mol Cell Cardiol; 2012 May; 52(5):1056-65. PubMed ID: 22326437
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-92a antagonism attenuates lipopolysaccharide (LPS)-induced pulmonary inflammation and injury in mice through suppressing the PTEN/AKT/NF-κB signaling pathway.
Fu L; Zhu P; Qi S; Li C; Zhao K
Biomed Pharmacother; 2018 Nov; 107():703-711. PubMed ID: 30138892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
